Nu Skin (NUS) reported earnings on Wed 12 Feb 20 (a/h)

** charts after earnings **

 

 

 

 

Nu Skin increases quarterly cash dividend to $0.375/share from $0.370/share

Nu Skin reports EPS in-line, revs in-line; guides Q1 EPS below consensus, revs below consensus; guides FY20 EPS below consensus, revs below consensus

Reports Q4 (Dec) earnings of $0.72 per share, in-line with the S&P Capital IQ Consensus of $0.72; revenues fell 14.6% year/year to $583.36 mln vs the $582.49 mln S&P Capital IQ Consensus.

Co issues downside guidance for Q1, sees EPS of $0.23-0.33 vs. $0.74 S&P Capital IQ Consensus; sees Q1 revs of $480-510 mln vs. $596.6 mln S&P Capital IQ Consensus.

Co issues downside guidance for FY20, sees EPS of $2.00-2.40 vs. $3.31 S&P Capital IQ Consensus; sees FY20 revs of $2.17-2.30 bln vs. $2.47 bln S&P Capital IQ Consensus.

Coronavirus Impact: Following the recent coronavirus outbreak, co has placed a temporary hold on all in-person meetings with its sales force and customers in Mainland China. While co expects the outbreak to significantly impact its business in the near term, co remains confident in its long-term opportunity in Mainland China and around the world. Its guidance reflects our current understanding of the situation.